Foxa2 regulates multiple pathways of insulin secretion

Journal of Clinical Investigation

Volumn 114, Issue 4, 2004, Pages 512-520

  Lantz, Kristen A ^a   Vatamaniuk, Marko Z ^a   Brestelli, John E ^a   Friedman, Joshua R ^a   Matschinsky, Franz M ^a,b   Kaestner, Klaus H ^a,c  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; AMINO ACID; GLUCOSE; HEPATOCYTE NUCLEAR FACTOR 3BETA; INSULIN; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2; ISOENZYME; RECEPTOR SUBTYPE; RNA; SHORT CHAIN LEVO 3 HYDROXYACYL COENZYME A DEHYDROGENASE; SULFONYLUREA RECEPTOR; SULFONYLUREA RECEPTOR 1; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; 3 HYDROXYACYL COENZYME A DEHYDROGENASE; ABC TRANSPORTER; ABCC8 PROTEIN, MOUSE; DNA BINDING PROTEIN; FOXA2 PROTEIN, MOUSE; INWARDLY RECTIFYING POTASSIUM CHANNEL; LUCIFERASE; MULTIDRUG RESISTANCE PROTEIN; NUCLEAR PROTEIN; TRANSACTIVATOR PROTEIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME DEFICIENCY; EXPERIMENTAL MODEL; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE MUTATION; GENE TARGETING; GENETIC CODE; HYPOGLYCEMIA; IN SITU HYBRIDIZATION; INSULIN RELEASE; MOUSE; NEWBORN; NONHUMAN; PANCREAS ISLET BETA CELL; PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA OF INFANCY; PRIORITY JOURNAL; ANIMAL; CELL LINE; CYTOLOGY; DOSE RESPONSE; DRUG INTERACTION; GENE DELETION; GENE EXPRESSION REGULATION; GENETICS; HAMSTER; KIDNEY; METABOLISM; MOUSE MUTANT; MOUSE STRAIN; PANCREAS ISLET; PROMOTER REGION; SECRETION; TRANSACTIVATION; TRANSGENIC MOUSE;

3-HYDROXYACYL COA DEHYDROGENASES; AMINO ACIDS; ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; CELL LINE; CRICETINAE; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; GENE DELETION; GENE EXPRESSION REGULATION; GLUCOSE; HEPATOCYTE NUCLEAR FACTOR 3-BETA; INSULIN; ISLETS OF LANGERHANS; KIDNEY; LUCIFERASES; MICE; MICE, INBRED STRAINS; MICE, KNOCKOUT; MICE, TRANSGENIC; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; NUCLEAR PROTEINS; POTASSIUM CHANNELS, INWARDLY RECTIFYING; PROMOTER REGIONS (GENETICS); TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

EID: 85047691646     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI21149     Document Type: Article

References (56)

1. Ben-Shushan, E., Marshak, S., Shoshkes, M., Cerasi, E., and Melloul, D. 2001. A pancreatic beta-cell-specific enhancer in the human PDX-1 gene is regulated by hepatocyte nuclear factor 3beta (HNF-3beta), HNF-1alpha, and SPs transcription factors. J. Biol. Chem. 276:17533-17540.
2. Sharma, S., et al. 1997. Hormonal regulation of an islet-specific enhancer in the pancreatic homeobox gene STF-1. Mol. Cell. Biol. 17:2598-2604.
3. Wu, K.L., et al. 1997. Hepatocyte nuclear factor 3beta is involved in pancreatic beta-cell-specific transcription of the pdx-1 gene. Mol. Cell. Biol. 17:6002-6013.
4. Weinstein, D.C., et al. 1994. The winged-helix transcription factor HNF-3 beta is required for notochord development in the mouse embryo. Cell. 78:575-588.
5. Ang, S.L., and Rossant, J. 1994. HNF-3 beta is essential for node and norochord formation in mouse development. Cell. 78:561-574.
6. Postic, C., et al. 1999. Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase. J. Biol. Chem. 274:305-315.
7. Sund, N.J., et al. 2001. Tissue-specific deletion of Foxa2 in pancreatic beta cells results in hyperinsulinemic hypoglycemia. Genes Dev. 15:1706-1715.
8. Aguilar-Bryan, L., et al. 1998. Toward understanding the assembly and structure of KATP channels. Physiol. Rev. 78:227-245.
9. + channels. Trends Neurosci. 21:288-294.
10. Wang, H., Gauthier, B.R., Hagenfeldt-Johansson, K.A., Iezzi, M., and Wollheim, C.B. 2002. Foxa2 (HNF3beta) controls multiple genes implicated in metabolism-secretion coupling of glucose-induced insulin release. J. Biol. Chem. 277:17564-17570.
11. Babenko, A.P., Aguilar-Bryan, L., and Bryan, J. 1998. A view of sur/KIR6.X, KATP channels. Annu. Rev. Physiol. 60:667-687.
12. + channel in insulin-secreting pancreatic beta-cells. J. Mol. Endocrinol. 22:113-123.
13. + channels in pancreatic beta-cells. Spare-channel hypothesis. Diabetes. 37:495-498.
14. + channels. J. Physiol. 528:509-520.
15. Meissner, T., Beinbrech, B., and Mayatepek, E. 1999. Congenital hyperinsulinism: molecular basis of a heterogeneous disease. Hum. Mutat. 13:351-361.
16. Thomas, P.M., et al. 1995. Mutations in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycemia of infancy. Science. 268:426-429.
17. Kane, C., et al. 1996. Loss of functional KATP channels in pancreatic beta-cells causes persistent hyperinsulinemic hypoglycemia of infancy. Nat. Med. 2:1344-1347.
18. Dunne, M.J., Cosgrove, K.E., Shepherd, R.M., and Ammala, C. 1999. Potassium channels, sulphonylurea receptors and control of insulin release. Trends Endocrinol. Metab. 10:146-152.
19. Kukuvitis, A., Deal, C., Arbour, L., and Polychronakos, C. 1997. An autosomal dominant form of familial persistent hyperinsulinemic hypoglycemia of infancy, not linked to the sulfonylurea receptor locus. J. Clin. Endocrinol. Metab. 82:1192-1194.
20. Edlund, H. 2002. Pancreatic organogenesis - developmental mechanisms and implications for therapy. Nat. Rev. Genet. 3:524-532.
21. Cherksey, B., and Altszuler, N. 1984. Tolbutamide and glyburide differ in effectiveness to displace alpha- and beta-adrenergic radioligands in pancreatic islet cells and membranes. Diabetes. 33:499-503.
22. Gorus, F.K., Schuit, F.C., In't Veld, P.A., Gepts, W., and Pipeleers, D.G. 1988. Interaction of sulfonylureas with pancreatic beta-cells. A study with glyburide. Diabetes. 37:1090-1095.
23. Miki, T., et al. 1998. Defective insulin secretion and enhanced insulin action in KATP channel-deficient mice. Proc. Natl. Acad. Sci. U. S. A. 95:10402-10406.
24. ATP channel-independent regulation of insulin secretion. J. Biol. Chem. 275:9270-9277.
25. Shiota, C., et al. 2002. Sulfonylurea receptor type 1 knock-out mice have intact feeding-stimulated insulin secretion despite marked impairment in their response to glucose. J. Biol. Chem. 277:37176-37183.
26. Scearce, L.M., et al. 2002. Functional genomics of the endocrine pancreas: the pancreas clone set and PancChip, new resources for diabetes research. Diabetes. 51:1997-2004.
27. Kaestner, K.H., et al. 2003. Transcriptional program of the endocrine pancreas in mice and humans. Diabetes. 52:1604-1610.
28. Lee, C.S., et al. 2002. Foxa2 controls Pdx1 gene expression in pancreatic beta-cells in vivo. Diabetes. 51:2546-2551.
29. 2+- signaling in rat pancreatic beta-cells. Biochem. Biophys. Res. Commun. 235:619-624.
30. Barycki, J.J., et al. 1999. Biochemical characterization and crystal structure determination of human heart short chain L-3-hydroxyacyl-CoA dehydrogenase provide insights into catalytic mechanism. Biochemistry. 38:5786-5798.
31. Vredendaal, P.J., et al. 1996. Human short-chain L-3-hydroxyacyl-CoA dehydrogenase: cloning and characterization of the coding sequence. Biochem. Biophys. Res. Commun. 223:718-723.
32. Agren, A., Borg, K., Brolin, S.E., Carlman, J., and Lundqvist, G. 1977. Hydroxyacyl CoA dehydrogenase, an enzyme important in fat metabolism in different cell types in the islets of Langerhans. Diabete Metab. 3:169-172.
33. Hammar, H., and Berne, C. 1970. The activity of beta-hydroxyacyl-CoA dehydrogenase in the pancreatic islets of hyperglycaemic mice. Diabetologia. 6:526-528.
34. Clayton, P.T., et al. 2001. Hyperinsulinism in short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency reveals the importance of beta-oxidation in insulin secretion. J. Clin. Invest. 108:457-465. doi:10.1172/JCI200111294.
35. Eaton, S., et al. 2003. Short-chain 3-hydroxyacyl-CoA dehydrogenase deficiency associated with hyperinsulinism: a novel glucose-fatty acid cycle? Biochem. Soc. Trans. 31:1137-1139.
36. Molven, A., et al. 2004. Familial hyperinsulinemic hypoglycemia caused by a defect in the SCHAD enzyme of mitochondrial fatty acid oxidation. Diabetes. 53:221-227.
37. Overdier, D.G., Porcella, A., and Costa, R.H. 1994. The DNA-binding specificity of the hepatocyte nuclear factor 3/forkhead domain is influenced by amino-acid residues adjacent to the recognition helix. Mol. Cell. Biol. 14:2755-2766.
38. Hellerstrom, C., and Swenne, I. 1991. Functional maturation and proliferation of fetal pancreatic beta-cells. Diabetes. 40:89-93.
39. Freinkel, N., et al. 1984. Differential effects of age versus glycemic stimulation on the maturation of insulin stimulus-secretion coupling during culture of fetal rat islets. Diabetes. 33:1028-1038.
40. Eriksson, U., Andersson, A., Efendic, S., Elde, R., and Hellerstrom, C. 1980. Diabetes in pregnancy: effects on the foeral and newborn rat with particular regard to body weight, serum insulin concentration and pancreatic contents of insulin, glucagon and somatostatin. Acta Endocrinol. 94:354-364.
41. Girard, J.R., et al. 1973. Fuels, hormones, and liver metabolism at term and during the early postnatal period in the rat. J. Clin. Invest. 52:3190-3200.
42. Hughes, S.J. 1994. The role of reduced glucose transporter content and glucose metabolism in the immature secretory responses of fetal rat pancreatic islets. Diabetologia. 37:134-140.
43. + channels. Proc. Natl. Acad. Sci. U. S. A. 86:4505-4509.
44. Greenbaum, C.J., Havel, P.J., Taborsky, G.J., Jr., and Klaff, L.J. 1991. Intra-islet insulin permits glucose to directly suppress pancreatic A cell function. J. Clin. Invest. 88:767-773.
45. Ishihara, H., Maechler, P., Gjinovci, A., Herrera, P.L., and Wollheim, C.B. 2003. Islet beta-cell secretion determines glucagon release from neighbouring alpha-cells. Nat. Cell Biol. 5:330-335.
46. Prentki, M. 1996. New insights into pancreatic beta-cell metabolic signaling in insulin secretion. Eur. J. Endocrinol. 134:272-286.
47. Glaser, B., Thornton, P., Otonkoski, T., and Junien, C. 2000. Genetics of neonatal hyperinsulinism. Arch. Dis. Child. Fetal Neonatal Ed. 82:F79-F86.
48. Bennett, M.J., et al. 1999. Fatal hepatic short-chain L-3-hydroxyacyl-coenzyme A dehydrogenase deficiency: clinical, biochemical, and pathological studies on three subjects with this recently identified disorder of mitochondrial beta-oxidation. Pediatr. Dev. Pathol. 2:337-345.
49. Henquin, J.C. 2000. Triggering and amplifying pathways of regulation of insulin secretion by glucose. Diabetes. 49:1751-1760.
50. Wilkinson, D.G. 1992. In situ hybridization: a practical approach. IRL Press at Oxford University Press. New York, New York, USA. 163 pp.
51. Kaestner, K.H., Katz, J., Liu, Y., Drucker, D.J., and Schutz, G. 1999. Inactivation of the winged helix transcription factor HNF3alpha affects glucose homeostasis and islet glucagon gene expression in vivo. Genes Dev. 13:495-504.
52. Scharp, D.W., Kemp, C.B., Knight, M.J., Ballinger, W.F., and Lacy, P.E. 1973. The use of Ficoll in the preparation of viable islets of Langerhans from the rat pancreas. Transplantation. 16:686-689.
53. Hara, M., et al. 2003. Transgenic mice with green fluorescent protein-labeled pancreatic beta-cells. Am. J. Physiol. Endocrinol. Metab. 284:E177-E183.
54. Manduchi, E., et al. 2004. RAD and the RAD Study-Annotator: an approach to collection, organization, and exchange of all relevant information for high-throughput gene expression studies. Bioinformatics. 20:452-459.
55. Rozen, S., and Skaletsky, H. 2000. Primer3 on the WWW for general users and for biologist programmers. Methods Mol. Biol. 132:365-386.
56. Wells, J., and Farnham, P.J. 2002. Characterizing transcription factor binding sites using formaldehyde crosslinking and immunoprecipitation. Methods. 26:48-56.